The treatment of hypertension in patients with erectile dysfunction

被引:25
|
作者
Mikhailidis, DP
Khan, MA
Milionis, HJ
Morgan, RJ
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Mol Pathol & Clin Biochem, London NW3 2QG, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Urol, London NW3 2QG, England
关键词
beta-blockers; diuretics; doxazosin; erectile dysfunction; hypertension;
D O I
10.1185/0300799009117037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is another predictor of erectile dysfunction (ED). This is further evidence supporting a link between the pathogenesis of atherosclerotic disease ann ED. In one study (TOMHS) involving hypertensive patients, the incidence of ED was 14.4%. The drugs used to treat hypertension may cause ED. However, there is little trial-based evidence to indicate which drugs are more likely to cause this side effect. In general, thiazide diuretics and beta-blockers seem to cause ED more often. In contrast, the alpha-blocker doxazosin, has Mot been associated with an increased incidence of ED as a sine effect. Doxazosin also improves urinary flow in patients with benign prostatic hyperplasia (BPH). This condition is common in elderly men as is hypertension and ED. Therefore, doxazosin may present a special advantage among this group of patients. This alpha-blocker would also be a good choice in patients with impaired glucose tolerance/diabetes because it improves insulin sensitivity. Moreover, ED and hypertension are more prevalent among diabetics. On a more speculative note, doxazosin may potentiate the therapeutic impact of specific treatments for ED.
引用
收藏
页码:S31 / S36
页数:6
相关论文
共 50 条
  • [31] Cigarette smoking, hypertension and erectile dysfunction
    Ledda, A
    CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 : S13 - S16
  • [32] Hypertension is associated with severe erectile dysfunction
    Burchardt, M
    Burchardt, T
    Baer, L
    Kiss, AJ
    Pawar, RV
    Shabsigh, A
    De la Taille, A
    Hayek, OR
    Shabsigh, R
    JOURNAL OF UROLOGY, 2000, 164 (04): : 1188 - 1191
  • [33] Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the erectile dysfunction observational study
    Haro, JM
    Beardsworth, A
    Casariego, J
    Gavart, S
    Hatzichristou, D
    Martin-Morales, A
    Schmitt, H
    Mirone, V
    Needs, N
    Riley, A
    Varanese, L
    Von Keitz, A
    Kontodimas, S
    JOURNAL OF SEXUAL MEDICINE, 2006, 3 (03): : 530 - 540
  • [34] STATIN TREATMENT IN ERECTILE DYSFUNCTION PATIENTS WITH OBESITY AND HYPERCHOLESTEROLEMIA
    Tomada, I
    Tomada, N.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 232 - 232
  • [35] Erectile dysfunction treatment with Uprima in Poland - Patients opinions
    Starowicz, ZL
    SEXUALITY AND DISABILITY, 2004, 22 (04) : 249 - 249
  • [36] Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction
    Luis Fernando Valladales-Restrepo
    Jorge Enrique Machado-Alba
    International Journal of Clinical Pharmacy, 2021, 43 : 900 - 908
  • [37] Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction
    Valladales-Restrepo, Luis Fernando
    Machado-Alba, Jorge Enrique
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 900 - 908
  • [38] COMBINED TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH SECONDARY HYPOGONADISM
    Gorpynchenko, I
    Romaniuk, M.
    Gurzhenko, J.
    Imshinetskaja, L.
    Aksenov, P.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 366 - 366
  • [39] Vardenafil in patients with erectile dysfunction: Achieving treatment optimization
    Hellstrom, WJG
    Elhilali, M
    Homering, M
    Taylor, T
    Gittleman, M
    JOURNAL OF ANDROLOGY, 2005, 26 (05): : 604 - 609
  • [40] Research instruments for the diagnosis and treatment of patients with erectile dysfunction
    Rosen, Raymond C.
    Althof, Stanley E.
    Giuliano, Francois
    UROLOGY, 2006, 68 (3A) : 6 - 16